- Wiley author
- Former customer excellence leader, Pfizer and Bayer
- Reuters Events speaker: Pharma USA 2025 and Pharma Customer Engagement USA
Science that never reaches the patient helps no one.
In some therapeutic areas, up to half of written prescriptions never become therapy. We rebuild the commercial system to a consumer-grade standard to close that gap.
Pharma’s commercial problem is value leakage after the script.
-
Promotion runs as a system. What follows the script does not.
Field, access, specialty pharmacy, patient services, reimbursement and medical each work from their own data and their own measure of success.
-
Consumer-grade expectations make leakage a competitive risk.
Patients and HCPs compare every handoff with the best service they get anywhere. Companies that close the gap take share.
-
The loss is large and mostly invisible.
Business reviews track scripts written, so value lost after the script rarely appears in any report.
One operating system connects brand, field and culture.
It runs experience with the same discipline as promotion. Brand growth and field performance rest on a culture of Customer Excellence.
Accelerate brand growth
For brands with strong scripts and stalled revenue.
We find where demand fails to become patients on therapy, price each loss and recover it.
Explore brand →
Elevate field performance
For field teams whose insight never turns into action.
We turn what the field sees into barriers removed, and measure the field on patient progress.
Explore field →
Embed customer excellence
For leaders whose gains fade after each program.
We write Customer Excellence into decision rights, routines and measures. Brand and field gains then hold.
Explore culture →